The Global Psychiatric Digital Biomarkers Market Size is Anticipated to Exceed USD 3879.4 Million by 2033, Growing at a CAGR of 22.43% from 2023 to 2033. The psychiatric digital biomarkers market is being driven by technological improvements, increased mental health awareness, integration into healthcare systems, tailored treatment approaches, and rising investments, resulting in tremendous growth potential during the forecast period.